Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: BuySellSignals Research
$5.00
Provider: Wright Reports
$75.00
Provider: BuySellSignals Research
$5.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Glenmark Pharmaceuticals Ltd Announces Issue Of Equity Pursuant To Exercise Of Options


Thursday, 2 Aug 2012 07:28am EDT 

Glenmark Pharmaceuticals Ltd announced that the board of directors at its meeting held on August 02, 2012, have allotted 33,500 shares to the employees of the Company on exercise of options. 

Latest Key Developments in Pharmaceuticals

Company Quote

537.35
-26.25 -4.66%
11 Jul 2014